Triglyceride-glucose index as a suitable non-insulin-based insulin resistance marker to predict cardiovascular events in patients undergoing complex coronary artery intervention: a large-scale cohort study

[1]  Rui Zhang,et al.  Discordance Between Neutrophil to Lymphocyte Ratio and High Sensitivity C-Reactive Protein to Predict Clinical Events in Patients with Stable Coronary Artery Disease: A Large-Scale Cohort Study , 2023, Journal of inflammation research.

[2]  Guofeng Gao,et al.  High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study , 2023, Cardiovascular Diabetology.

[3]  S. Yuan,et al.  Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes. , 2023, Journal of endocrinological investigation.

[4]  D. Yin,et al.  High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study , 2023, Cardiovascular Diabetology.

[5]  Zenglei Zhang,et al.  Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study , 2023, Cardiovascular Diabetology.

[6]  Chenxi Song,et al.  Diabetes Mellitus with Mild or Moderate Kidney Dysfunction is Associated with Poor Prognosis in Patients with Coronary Artery Disease: A Large-Scale Cohort Study. , 2023, Diabetes research and clinical practice.

[7]  C. Zhong,et al.  Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data , 2023, Cardiovascular Diabetology.

[8]  Xuelian Fu,et al.  Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease , 2022, Diabetology & metabolic syndrome.

[9]  Li-Yu Daisy Liu,et al.  The impact of the metabolic score for insulin resistance on cardiovascular disease: a 10-year follow-up cohort study , 2022, Journal of Endocrinological Investigation.

[10]  Xiang Wang,et al.  Association between the triglyceride–glucose index and severity of coronary artery disease , 2022, Cardiovascular Diabetology.

[11]  Chenxi Song,et al.  High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study , 2022, Cardiovascular Diabetology.

[12]  Wei Li,et al.  Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease , 2022, Frontiers in Cardiovascular Medicine.

[13]  Guangwei Pan,et al.  Triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China , 2022, Cardiovascular Diabetology.

[14]  Jian Li,et al.  Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations , 2022, Cardiovascular Diabetology.

[15]  Hyo‐Soo Kim,et al.  Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS Trial. , 2022, JAMA cardiology.

[16]  E. Huang,et al.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. , 2021, Diabetes care.

[17]  Theresa M. Beckie,et al.  2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2021, Journal of the American College of Cardiology.

[18]  Yan Liu,et al.  Association between the triglyceride glucose index and coronary collateralization in coronary artery disease patients with chronic total occlusion lesions , 2021, Lipids in Health and Disease.

[19]  Hongliang Cong,et al.  Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins , 2021, Frontiers in Cardiovascular Medicine.

[20]  Xiuhua Guo,et al.  Association of TyG index and TG/HDL-C ratio with arterial stiffness progression in a non-normotensive population , 2021, Cardiovascular Diabetology.

[21]  Meizi Cui,et al.  Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies , 2021, Cardiovascular Diabetology.

[22]  K. Kario,et al.  Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension , 2021, Journal of clinical hypertension.

[23]  B. Xu,et al.  Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study , 2020, Journal of interventional cardiology.

[24]  Guofeng Gao,et al.  Validating the Performance of 5 Risk Scores for Major Adverse Cardiac Events in Patients Who Achieved Complete Revascularization After Percutaneous Coronary Intervention. , 2019, The Canadian journal of cardiology.

[25]  Xiaohui Zhao,et al.  The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome , 2019, Disease markers.

[26]  Peng Jin,et al.  Association Between TG-to-HDL-C Ratio and In-Stent Stenosis Under Optical Coherence Tomography Guidance , 2018, Journal of Medical Systems.

[27]  Jackson T. Wright,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[28]  Wilbert S Aronow,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[29]  G. Reaven,et al.  Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[30]  Deepak L. Bhatt,et al.  Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. , 2016, Journal of the American College of Cardiology.

[31]  Yucheng Chen,et al.  The Association between Triglyceride/High-Density Lipoprotein Cholesterol Ratio and All-Cause Mortality in Acute Coronary Syndrome after Coronary Revascularization , 2015, PloS one.

[32]  K. Bornfeldt,et al.  Insulin resistance, hyperglycemia, and atherosclerosis. , 2011, Cell metabolism.

[33]  Dick M. Goedhart,et al.  Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial , 2011, Circulation. Cardiovascular interventions.

[34]  G. Pelissero,et al.  Risk of Assessing Mortality Risk in Elective Cardiac Operations: Age, Creatinine, Ejection Fraction, and the Law of Parsimony , 2009, Circulation.

[35]  Song-min Huang,et al.  Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[36]  R. Muniyappa,et al.  Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. , 2008, American journal of physiology. Endocrinology and metabolism.